The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Item
http://www.wikidata.org/entity/Q34221605
The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma.Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature PigsTargeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasmsSUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.ALK: a tyrosine kinase target for cancer therapy.LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma.NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma.
P2860

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Item
http://www.wikidata.org/entity/Q34221605
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@ast
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@en
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@nl
type
label
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@ast
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@en
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@nl
prefLabel
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@ast
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@en
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
The ALK inhibitor ASP3026 erad ...... emic xenograft lymphoma model.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932